Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Hyperglycemia-induced P300/CBP acetyltransferase drives ZEB2-mediated proinflammatory macrophages and delays wound healing
Soumyajit Roy, Debarun Patra, Palla Ramprasad, Shivam Sharma, Parul Katiyar, Ashvind Bawa, Kanhaiya Singh, Kulbhushan Tikoo, Suman Dasgupta, Chandan K. Sen, Durba Pal
Soumyajit Roy, Debarun Patra, Palla Ramprasad, Shivam Sharma, Parul Katiyar, Ashvind Bawa, Kanhaiya Singh, Kulbhushan Tikoo, Suman Dasgupta, Chandan K. Sen, Durba Pal
View: Text | PDF
Research Article Dermatology Immunology Inflammation

Hyperglycemia-induced P300/CBP acetyltransferase drives ZEB2-mediated proinflammatory macrophages and delays wound healing

  • Text
  • PDF
Abstract

Chronic hyperglycemia changes the expression of various transcription factors and mRNA transcripts that impair cellular functionality and delay wound healing. Zinc finger E-box–binding homeobox 2 (ZEB2), a key transcription factor, maintains tissue-specific macrophage identities; however, its role in regulating macrophage polarization during wound healing under hyperglycemic conditions remains unclear. Here, we found that persistent hyperglycemia increases ZEB2 expression in wound macrophages via histone acetylation, contributing to chronic inflammation and delayed wound healing. Exposure to high glucose levels activated P300/CBP, a transcriptional coactivator involved in histone acetylation, which enhanced ZEB2 expression in wound macrophages. The forced expression of ZEB2 shifted macrophage polarity toward a proinflammatory state by upregulating myeloid lineage–directed transcription factors. Conversely, silencing Zeb2 at the wound site reduced hyperglycemia-induced macrophage inflammation. Topical application of C646, an inhibitor of P300, at the wound edges of streptozotocin-induced high-fat diet–fed diabetic mice significantly decreased ZEB2 expression, reduced inflammation, and accelerated wound healing. Therefore, targeted inhibition of P300 represents a promising therapeutic strategy for improving diabetic wound healing by modulating ZEB2-driven inflammation in wound macrophages.

Authors

Soumyajit Roy, Debarun Patra, Palla Ramprasad, Shivam Sharma, Parul Katiyar, Ashvind Bawa, Kanhaiya Singh, Kulbhushan Tikoo, Suman Dasgupta, Chandan K. Sen, Durba Pal

×

Figure 3

Inhibiting Zeb2 safeguards against hyperglycemia-induced macrophage inflammation and prevents their polarization.

Options: View larger image (or click on image) Download as PowerPoint
Inhibiting Zeb2 safeguards against hyperglycemia-induced macrophage infl...
Expression profile of HATs upon induction with HG was determined based on (A) relative mRNA abundance by qPCR and (B) immunostaining for P300 and HAT1 (scale bars: 30 μm, n = 3). *P < 0.05, **P < 0.01, ***P < 0.001 by paired, 2-tailed Student’s t test. Expression profile of HATs in human wound patient samples by (C) mRNA expression and (D) tissue immunostaining for P300 and HAT1 (scale bars: 100 μm, n = 3/group). *P < 0.05, ***P < 0.001, #P < 0.0001 by paired, 2-tailed Student’s t test. HAT expression in d7 mouse wound tissue by (E) relative mRNA expression and (F) tissue immunostaining with P300 (red) and HAT1 (green) antibodies (scale bars: 100 μm [higher magnification] and 500 μm [lower magnification]; n = 3/group). *P < 0.05, **P < 0.01, ***P < 0.001 by paired, 2-tailed Student’s t test. (G) The effect of Zeb2 inhibition was assessed by Western blot analysis of ZEB2 and p-NF-κB. The reduction in proinflammatory status upon Zeb2 inhibition revealed by (H) immunostaining (scale bars: 30 μm, n = 3) and (I and J) flow cytometric analysis of macrophage surface markers (n = 3). **P < 0.01 by paired, 2-tailed Student’s t test. (K) Culture media were analyzed for IL-1β and TNF-α by ELISA in control siRNA (Con-si) + HG and Zeb2 siRNA (Zeb2-si) + HG groups (n = 3). ***P < 0.001, #P < 0.0001 assessed with 1-way ANOVA followed by Tukey’s post hoc test. Experiments were repeated 3 times independently. Data are expressed as mean ± standard deviation. NS, not significant; ND, nondiabetic; DFU, diabetic foot ulcer; SD, standard diet; HFD, high-fat diet; PG, physiological glucose level; HG, hyperglycemia.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts